European Parliament approves 2024 accounts of the Joint Undertaking for the Innovative Medicines Initiative
10 Sep 2026Effective: 29 Apr 202620 views
Who is affected:
Companies and researchers participating in projects funded by the EU Innovative Medicines Initiative
Summary
The European Parliament approves the 2024 budget management of the European entity that finances innovative health research. It is an institutional financial control procedure.
Detailed analysis
PRO
Decision (EU) 2026/1682 approves the budget management for the 2024 financial year of the Joint Undertaking for the Innovative Medicines Initiative (IMI), a public-private EU body that co-finances R&D projects in health. This budget discharge act is the European Parliament's mechanism for democratic control over the ex…
PRO exclusive content
Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.
OJ:L_202601682: Decisión (UE) 2026/1682 del Parlamento Europeo, de 29 de abril de 2026, sobre la aprobación de la gestión en la ejecución del presupuesto de la Empresa Común para la Iniciativa de Salud Innovadora para el ejercicio 2024
The European Central Bank modifies how it internally delegates decisions on risk models used by major European banks. It affects banking supervision but does no...
Significant credit institutions directly supervised by the ECB
The European Central Bank allows its supervisory officials to directly approve restructuring plans for banking groups. It streamlines decision-making in Europea...
Significant banking groups supervised by the ECB and their supervision teams
The European Commission requires the registration of imports of steel shelving from China to be able to collect anti-dumping duties retroactively if dumping is ...
European importers of Chinese steel shelving, distributors and logistics sector
The European Commission authorizes the signing of agreements that update the monetary agreements with Andorra and San Marino, which use the euro without being E...
Financial entities, companies and citizens with economic activity in Andorra and San Marino
The European Commission approves ELOCLEAR biocide as an authorized product throughout the EU. This authorization permits its marketing and use in accordance wit...
Manufacturers, distributors and professional users of biocides in the EU
The EU administratively updates the authorization of the LANXESS CMIT/MIT biocide group. The changes are minor and do not alter the essential conditions of the ...
Manufacturers, distributors and industrial users of CMIT/MIT biocides in the EU
